Are colonoscopies to blame for the $2.7 trillion medical bill in the U.S.?

| | Health Imaging | Economics

The price discrepancy between colonoscopies performed in the U.S. and exams in other countries is at the heart of escalating medical costs in the U.S., according to an article in the NY Times. Colonoscopies are over-performed and over-priced in the U.S., the author asserts. Read more at the link below.

The $2.7 Trillion Medical Bill

Related Content

Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers
Operations manager, doctors charged in $70M imaging kickback scheme
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT
A closer look at how FDA's flurpiridaz approval will impact nuclear cardiology
Cath lab techs and nurses see new normal with post-COVID pay

Around the web

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care.